-
Je něco špatně v tomto záznamu ?
Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner
K. Holubova, L. Kleteckova, M. Skurlova, J. Ricny, A. Stuchlik, K. Vales,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT13403
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
ProQuest Central
od 1997-02-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 1996-10-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 1997-02-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-02-01 do Před 1 rokem
Psychology Database (ProQuest)
od 1997-02-01 do Před 1 rokem
- MeSH
- antidepresiva farmakologie MeSH
- bludiště - učení účinky léků MeSH
- bulbus olfactorius fyziologie MeSH
- hipokampus účinky léků metabolismus MeSH
- ketamin antagonisté a inhibitory farmakologie MeSH
- krysa rodu rattus MeSH
- mozkový neurotrofický faktor metabolismus MeSH
- potkani Wistar MeSH
- prefrontální mozková kůra účinky léků metabolismus MeSH
- sirolimus farmakologie MeSH
- TOR serin-threoninkinasy účinky léků metabolismus MeSH
- učení vyhýbat se účinky léků MeSH
- úzkost psychologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVE: The aim of our study was to test whether ketamine produces an antidepressant effect in animal model of olfactory bulbectomy and assess the role of mammalian target of rapamycin (mTOR) pathway in ketamine's antidepressant effect. METHODS: Bulbectomized (OBX) rats and sham controls were assigned to four subgroups according to the treatment they received (ketamine, saline, ketamine + rapamycin, and saline + rapamycin). The animals were subjected to open field (OF), elevated plus maze (EPM), passive avoidance (PA), Morris water maze (MWM), and Carousel maze (CM) tests. Blood samples were collected before and after drug administration for analysis of phosphorylated mTOR level. After behavioral testing, brains were removed for evaluation of brain-derived neurotrophic factor (BDNF) in prefrontal cortex (PFC) and hippocampus. RESULTS: Ketamine normalized hyperactivity of OBX animals in EPM and increased the time spent in open arms. Rapamycin pretreatment resulted in elimination of ketamine effect in EPM test. In CM test, ketamine + rapamycin administration led to cognitive impairment not observed in saline-, ketamine-, or saline + rapamycin-treated OBX rats. Prefrontal BDNF content was significantly decreased, and level of mTOR was significantly elevated in OBX groups. CONCLUSIONS: OBX animals significantly differed from sham controls in most of the tests used. Treatment had more profound effect on OBX phenotype than controls. Pretreatment with rapamycin eliminated the anxiolytic and antidepressant effects of ketamine in task-dependent manner. The results indicate that ketamine + rapamycin application resulted in impaired stress responses manifested by cognitive deficits in active place avoidance (CM) test. Intensity of stressor (mild vs. severe) used in the behavioral tests had opposite effect on controls and on OBX animals.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17014001
- 003
- CZ-PrNML
- 005
- 20181026092655.0
- 007
- ta
- 008
- 170413s2016 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00213-016-4256-3 $2 doi
- 035 __
- $a (PubMed)27004790
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Holubová, Kristína $u The Institute of Physiology, Academy of Sciences of the Czech Republic, v.v.i., Videnska 1083, 14220, Prague, Czech Republic. National Institute of Mental Health, Topolova 748, 250 67 Klecany, Prague East, Czech Republic. $7 xx0278720
- 245 10
- $a Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner / $c K. Holubova, L. Kleteckova, M. Skurlova, J. Ricny, A. Stuchlik, K. Vales,
- 520 9_
- $a OBJECTIVE: The aim of our study was to test whether ketamine produces an antidepressant effect in animal model of olfactory bulbectomy and assess the role of mammalian target of rapamycin (mTOR) pathway in ketamine's antidepressant effect. METHODS: Bulbectomized (OBX) rats and sham controls were assigned to four subgroups according to the treatment they received (ketamine, saline, ketamine + rapamycin, and saline + rapamycin). The animals were subjected to open field (OF), elevated plus maze (EPM), passive avoidance (PA), Morris water maze (MWM), and Carousel maze (CM) tests. Blood samples were collected before and after drug administration for analysis of phosphorylated mTOR level. After behavioral testing, brains were removed for evaluation of brain-derived neurotrophic factor (BDNF) in prefrontal cortex (PFC) and hippocampus. RESULTS: Ketamine normalized hyperactivity of OBX animals in EPM and increased the time spent in open arms. Rapamycin pretreatment resulted in elimination of ketamine effect in EPM test. In CM test, ketamine + rapamycin administration led to cognitive impairment not observed in saline-, ketamine-, or saline + rapamycin-treated OBX rats. Prefrontal BDNF content was significantly decreased, and level of mTOR was significantly elevated in OBX groups. CONCLUSIONS: OBX animals significantly differed from sham controls in most of the tests used. Treatment had more profound effect on OBX phenotype than controls. Pretreatment with rapamycin eliminated the anxiolytic and antidepressant effects of ketamine in task-dependent manner. The results indicate that ketamine + rapamycin application resulted in impaired stress responses manifested by cognitive deficits in active place avoidance (CM) test. Intensity of stressor (mild vs. severe) used in the behavioral tests had opposite effect on controls and on OBX animals.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antidepresiva $x farmakologie $7 D000928
- 650 _2
- $a úzkost $x psychologie $7 D001007
- 650 _2
- $a učení vyhýbat se $x účinky léků $7 D001362
- 650 _2
- $a mozkový neurotrofický faktor $x metabolismus $7 D019208
- 650 _2
- $a hipokampus $x účinky léků $x metabolismus $7 D006624
- 650 _2
- $a ketamin $x antagonisté a inhibitory $x farmakologie $7 D007649
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a bludiště - učení $x účinky léků $7 D018782
- 650 _2
- $a bulbus olfactorius $x fyziologie $7 D009830
- 650 _2
- $a prefrontální mozková kůra $x účinky léků $x metabolismus $7 D017397
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a sirolimus $x farmakologie $7 D020123
- 650 _2
- $a TOR serin-threoninkinasy $x účinky léků $x metabolismus $7 D058570
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kleteckova, Lenka $u The Institute of Physiology, Academy of Sciences of the Czech Republic, v.v.i., Videnska 1083, 14220, Prague, Czech Republic. National Institute of Mental Health, Topolova 748, 250 67 Klecany, Prague East, Czech Republic.
- 700 1_
- $a Škurlová, Martina $u The Institute of Physiology, Academy of Sciences of the Czech Republic, v.v.i., Videnska 1083, 14220, Prague, Czech Republic. National Institute of Mental Health, Topolova 748, 250 67 Klecany, Prague East, Czech Republic. $7 xx0226211
- 700 1_
- $a Říčný, Jan $u National Institute of Mental Health, Topolova 748, 250 67 Klecany, Prague East, Czech Republic. $7 xx0153151
- 700 1_
- $a Stuchlík, Aleš, $u The Institute of Physiology, Academy of Sciences of the Czech Republic, v.v.i., Videnska 1083, 14220, Prague, Czech Republic. $d 1974- $7 xx0014340
- 700 1_
- $a Valeš, Karel $u The Institute of Physiology, Academy of Sciences of the Czech Republic, v.v.i., Videnska 1083, 14220, Prague, Czech Republic. vales@biomed.cas.cz. National Institute of Mental Health, Topolova 748, 250 67 Klecany, Prague East, Czech Republic. vales@biomed.cas.cz. $7 xx0070865
- 773 0_
- $w MED00003990 $t Psychopharmacology $x 1432-2072 $g Roč. 233, č. 11 (2016), s. 2077-2097
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27004790 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20181026093205 $b ABA008
- 999 __
- $a ok $b bmc $g 1200466 $s 974779
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 233 $c 11 $d 2077-2097 $e 20160323 $i 1432-2072 $m Psychopharmacology $n Psychopharmacology $x MED00003990
- GRA __
- $a NT13403 $p MZ0
- LZP __
- $a Pubmed-20170413